Conference
Correlation of Bridging Therapy (BT) and Lymphodepleting Chemotherapy (LDC) with clinical outcomes in patients (pts) with relapsed/refractory Diffuse Large B-cell Lymphoma (r/r DLBCL) treated with tisagenlecleucel
Authors
Andreadis C; Tam CS; Borchmann P; Jaeger U; McGuirk JP; Holte H; Waller EK; Jaglowski S; Bishop MR; Foley SR
Volume
43
Pagination
pp. 62-63
Publisher
KARGER
Publication Date
October 1, 2020
Conference proceedings
ONCOLOGY RESEARCH AND TREATMENT
Issue
SUPPL 4
ISSN
2296-5270